Association of Atrial Fibrillation with Diabetes Mellitus, High Risk Comorbidities.
作者信息
PhD Leonida Gherasim Md PhD
机构信息
Professor, "Carol Davila" University of Medicine and Pharmacy, Bucharest, Romania.
出版信息
Maedica (Bucur). 2022 Mar;17(1):143-152. doi: 10.26574/maedica.2022.17.1.143.
Abstract
摘要
相似文献
1
Association of Atrial Fibrillation with Diabetes Mellitus, High Risk Comorbidities.心房颤动与糖尿病及高风险合并症的关联
Maedica (Bucur). 2022 Mar;17(1):143-152. doi: 10.26574/maedica.2022.17.1.143.
2
Association of Diabetes With Atrial Fibrillation Phenotype and Cardiac and Neurological Comorbidities: Insights From the Swiss-AF Study.糖尿病与心房颤动表型及心脏和神经系统合并症的相关性：来自瑞士房颤研究的新见解。
J Am Heart Assoc. 2021 Nov 16;10(22):e021800. doi: 10.1161/JAHA.121.021800. Epub 2021 Nov 10.
3
Risk of atrial fibrillation in diabetes mellitus: A nationwide cohort study.糖尿病患者发生心房颤动的风险：一项全国性队列研究。
Eur J Prev Cardiol. 2016 Apr;23(6):621-7. doi: 10.1177/2047487315599892. Epub 2015 Aug 7.
4
Glycemic Status and Thromboembolic Risk in Patients With Atrial Fibrillation and Type 2 Diabetes Mellitus: A Danish Cohort Study.血糖状态与 2 型糖尿病合并心房颤动患者的血栓栓塞风险：一项丹麦队列研究。
Circ Arrhythm Electrophysiol. 2019 May;12(5):e007030. doi: 10.1161/CIRCEP.118.007030.
5
Effect of Dapagliflozin on Atrial Fibrillation in Patients With Type 2 Diabetes Mellitus: Insights From the DECLARE-TIMI 58 Trial.达格列净对 2 型糖尿病患者心房颤动的影响：来自 DECLARE-TIMI 58 试验的见解。
Circulation. 2020 Apr 14;141(15):1227-1234. doi: 10.1161/CIRCULATIONAHA.119.044183. Epub 2020 Jan 27.
6
Diabetes mellitus, blood glucose and the risk of atrial fibrillation: A systematic review and meta-analysis of cohort studies.糖尿病、血糖与心房颤动风险：队列研究的系统评价和荟萃分析。
J Diabetes Complications. 2018 May;32(5):501-511. doi: 10.1016/j.jdiacomp.2018.02.004. Epub 2018 Feb 17.
7
Risk Factors for Atrial Fibrillation in People With Type 1 Diabetes: An Observational Cohort Study of 36,258 Patients From the Swedish National Diabetes Registry.1 型糖尿病患者心房颤动的危险因素：来自瑞典国家糖尿病登记处的 36258 例患者的观察性队列研究。
Diabetes Care. 2019 Aug;42(8):1530-1538. doi: 10.2337/dc18-2457. Epub 2019 Jun 6.
8
Duration of Diabetes Mellitus and Risk of Thromboembolism and Bleeding in Atrial Fibrillation: Nationwide Cohort Study.糖尿病病程与心房颤动患者血栓栓塞及出血风险：全国性队列研究
Stroke. 2015 Aug;46(8):2168-74. doi: 10.1161/STROKEAHA.115.009371. Epub 2015 Jul 7.
9
High overall cardiovascular risk and mortality in patients with atrial fibrillation and diabetes: A nationwide report.心房颤动合并糖尿病患者的总体心血管风险和死亡率：一项全国性报告。
Diab Vasc Dis Res. 2018 Jan;15(1):31-38. doi: 10.1177/1479164117735013. Epub 2017 Oct 20.
10
[Effect of diabetes mellitus in recovery and maintenance of sinus rhythm in patients with persistent atrial fibrillation].[糖尿病对持续性心房颤动患者窦性心律恢复及维持的影响]
Srp Arh Celok Lek. 2002 May-Jun;130(5-6):189-92. doi: 10.2298/sarh0206189p.
引用本文的文献
1
Debating the link between atrial fibrillation and psychiatric diseases through Ca/cAMP signaling.通过钙/环磷酸腺苷信号传导探讨心房颤动与精神疾病之间的联系。
World J Psychiatry. 2025 Jul 19;15(7):107130. doi: 10.5498/wjp.v15.i7.107130.
2
Racial and Gender Differences in Cardiorespiratory Fitness and Atrial Fibrillation.心肺适能与心房颤动中的种族和性别差异
Rev Cardiovasc Med. 2024 Jul 11;25(7):261. doi: 10.31083/j.rcm2507261. eCollection 2024 Jul.
3
Association of Body Mass Index with Outcomes in Patients with Atrial Fibrillation: Analysis from the (JoFib) Registry.体重指数与心房颤动患者结局的关系：来自（JoFib）登记处的分析。
Vasc Health Risk Manag. 2024 Mar 5;20:89-96. doi: 10.2147/VHRM.S444894. eCollection 2024.
4
Factor Xa inhibitors versus warfarin in patients with non-valvular atrial fibrillation and diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials.非瓣膜性心房颤动合并糖尿病患者中，Xa因子抑制剂与华法林的比较：随机对照试验的系统评价和荟萃分析
Ann Med Surg (Lond). 2024 Jan 3;86(2):986-993. doi: 10.1097/MS9.0000000000001621. eCollection 2024 Feb.
5
Efficacy of the combination of Chinese herbal medicine and negative pressure wound therapy in the treatment of patients with diabetic foot ulcer: A meta-analysis.中药联合负压伤口疗法治疗糖尿病足溃疡的疗效：一项荟萃分析。
Int Wound J. 2024 Apr;21(4):e14536. doi: 10.1111/iwj.14536. Epub 2023 Dec 8.
6
Metabolic Syndrome: A Strange Companion of Atrial Fibrillation; A Blessing in Disguise from the Neuropsychiatric Point of View.代谢综合征：心房颤动的奇特伴友；从神经精神病学角度看实则因祸得福。
Biomedicines. 2023 Jul 17;11(7):2012. doi: 10.3390/biomedicines11072012.
7
Increased small extracellular vesicle levels and decreased miR-126 levels associated with atrial fibrillation and coexisting diabetes mellitus.与心房颤动和并存的糖尿病相关的小细胞外囊泡水平升高和 miR-126 水平降低。
Clin Cardiol. 2023 Nov;46(11):1326-1336. doi: 10.1002/clc.24115. Epub 2023 Aug 7.
8
Increased Left Atrial Stiffness is Significantly Associated with Paroxysmal Atrial Fibrillation in Diabetic Patients.左心房僵硬度增加与糖尿病患者阵发性心房颤动显著相关。
Diabetes Metab Syndr Obes. 2023 Jul 11;16:2077-2087. doi: 10.2147/DMSO.S417675. eCollection 2023.
本文引用的文献
1
Catheter ablation as first-line treatment for paroxysmal atrial fibrillation: a systematic review and meta-analysis.导管消融作为阵发性心房颤动的一线治疗方法：系统评价和荟萃分析。
Heart. 2021 Oct;107(20):1630-1636. doi: 10.1136/heartjnl-2021-319496. Epub 2021 Jul 14.
2
Ablation Versus Drug Therapy for Atrial Fibrillation in Heart Failure: Results From the CABANA Trial.心房颤动心力衰竭中消融与药物治疗的比较：CABANA 试验结果。
Circulation. 2021 Apr 6;143(14):1377-1390. doi: 10.1161/CIRCULATIONAHA.120.050991. Epub 2021 Feb 8.
3
Concomitant diabetes with atrial fibrillation and anticoagulation management considerations.糖尿病合并心房颤动及抗凝管理考量
Eur Heart J Suppl. 2020 Dec 22;22(Suppl O):O78-O86. doi: 10.1093/eurheartj/suaa182. eCollection 2020 Dec.
4
2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC.2020年欧洲心脏病学会（ESC）与欧洲心胸外科学会（EACTS）合作制定的心房颤动诊断和管理指南：欧洲心脏病学会（ESC）心房颤动诊断和管理特别工作组，由ESC欧洲心律协会（EHRA）特别贡献制定。
Eur Heart J. 2021 Feb 1;42(5):373-498. doi: 10.1093/eurheartj/ehaa612.
5
Effect of Dapagliflozin on Atrial Fibrillation in Patients With Type 2 Diabetes Mellitus: Insights From the DECLARE-TIMI 58 Trial.达格列净对 2 型糖尿病患者心房颤动的影响：来自 DECLARE-TIMI 58 试验的见解。
Circulation. 2020 Apr 14;141(15):1227-1234. doi: 10.1161/CIRCULATIONAHA.119.044183. Epub 2020 Jan 27.
6
Impact of Type-2 Diabetes Mellitus on the Outcomes of Catheter Ablation of Atrial Fibrillation (European Observational Multicentre Study).2 型糖尿病对心房颤动导管消融结局的影响（欧洲观察性多中心研究）。
Am J Cardiol. 2020 Mar 15;125(6):901-906. doi: 10.1016/j.amjcard.2019.12.037. Epub 2019 Dec 30.
7
Risk of atrial fibrillation in persons with type 2 diabetes and the excess risk in relation to glycaemic control and renal function: a Swedish cohort study.2 型糖尿病患者发生心房颤动的风险以及与血糖控制和肾功能的关系：一项瑞典队列研究。
Cardiovasc Diabetol. 2020 Jan 18;19(1):9. doi: 10.1186/s12933-019-0983-1.
8
2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD.2019年欧洲心脏病学会（ESC）与欧洲糖尿病研究协会（EASD）合作制定的糖尿病、糖尿病前期和心血管疾病指南。
Eur Heart J. 2020 Jan 7;41(2):255-323. doi: 10.1093/eurheartj/ehz486.
9
Atrial Fibrillation and Diabetes Mellitus: JACC Review Topic of the Week.心房颤动与糖尿病：美国心脏病学会评论专题之周更
J Am Coll Cardiol. 2019 Aug 27;74(8):1107-1115. doi: 10.1016/j.jacc.2019.07.020.
10
Atrial Fibrillation and Diabetes Mellitus: Can We Modify Stroke Risk Through Glycemic Control?心房颤动与糖尿病：我们能否通过血糖控制来降低中风风险？
Circ Arrhythm Electrophysiol. 2019 May;12(5):e007351. doi: 10.1161/CIRCEP.119.007351.
Zotero 插件